FT
Fiduciary Trust Portfolio holdings
AUM
$8.13B
This Quarter Return
+3.83%
1 Year Return
+17.24%
3 Year Return
+70.37%
5 Year Return
+113.33%
10 Year Return
+243.4%
AUM
$6.66B
AUM Growth
+$144M
(+2.2%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
45.21%
Holding
654
New
12
Increased
175
Reduced
300
Closed
25
Top Buys
| 1 |
WisdomTree US LargeCap Fund
EPS
|
$49.5M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$24.7M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$13.9M |
| 4 |
Palo Alto Networks
PANW
|
$6.07M |
| 5 |
Schwab US Broad Market ETF
SCHB
|
$4.14M |
Top Sells
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$44.4M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
$26.2M |
| 3 |
Moderna
MRNA
|
$6.65M |
| 4 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$5.3M |
| 5 |
Apple
AAPL
|
$5.26M |
Sector Composition
| 1 | Technology | 16.3% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 7.42% |
| 4 | Financials | 5.25% |
| 5 | Industrials | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38B
| $9.36M | 0.14% |
186,886
-18,947
| -9% | -$949K |
|
102
Apellis Pharmaceuticals
APLS
$3.51B
| $9.22M | 0.14% |
240,286
-700
| -0.3% | -$26.9K |
|
103
IBM
IBM
$227B
| $9.14M | 0.14% |
52,860
-367
| -0.7% | -$63.5K |
|
104
Zoetis
ZTS
$67.6B
| $9.13M | 0.14% |
52,647
-2,463
| -4% | -$427K |
|
105
O'Reilly Automotive
ORLY
$88.1B
| $9.09M | 0.14% |
129,120
+5,685
| +5% | +$400K |
|
106
Pfizer
PFE
$141B
| $9.06M | 0.14% |
323,911
-13,160
| -4% | -$368K |
|
107
Regeneron Pharmaceuticals
REGN
$59.8B
| $8.93M | 0.13% |
8,496
+58
| +0.7% | +$61K |
|
108
Valero Energy
VLO
$48.3B
| $8.82M | 0.13% |
56,255
+89
| +0.2% | +$14K |
|
109
Becton Dickinson
BDX
$54.3B
| $8.61M | 0.13% |
36,860
+226
| +0.6% | +$52.8K |
|
110
Walmart
WMT
$793B
| $8.59M | 0.13% |
126,903
-3,320
| -3% | -$225K |
|
111
General Dynamics
GD
$86.8B
| $8.3M | 0.12% |
28,603
-141
| -0.5% | -$40.9K |
|
112
iShares MSCI Emerging Markets ETF
EEM
$19B
| $8.24M | 0.12% |
193,466
-12,048
| -6% | -$513K |
|
113
Canadian Natural Resources
CNQ
$65B
| $8.21M | 0.12% |
230,494
-380
| -0.2% | -$13.5K |
|
114
Parker-Hannifin
PH
$94.8B
| $8.17M | 0.12% |
16,157
-160
| -1% | -$80.9K |
|
115
Vanguard ESG International Stock ETF
VSGX
$4.94B
| $8.08M | 0.12% |
141,061
-6,197
| -4% | -$355K |
|
116
SPDR Gold Trust
GLD
$111B
| $7.87M | 0.12% |
36,620
+296
| +0.8% | +$63.6K |
|
|
117
Schwab US Broad Market ETF
SCHB
$36.1B
| $7.86M | 0.12% |
374,853
+197,370
| +111% | +$4.14M |
|
118
Vanguard International High Dividend Yield ETF
VYMI
$11.7B
| $7.81M | 0.12% |
114,024
+111
| +0.1% | +$7.61K |
|
119
Chubb
CB
$111B
| $7.68M | 0.12% |
30,119
-341
| -1% | -$87K |
|
120
Bristol-Myers Squibb
BMY
$96.7B
| $7.53M | 0.11% |
181,425
-32,747
| -15% | -$1.36M |
|
121
iShares Russell 3000 ETF
IWV
$16.5B
| $7.5M | 0.11% |
24,292
-67
| -0.3% | -$20.7K |
|
122
Texas Instruments
TXN
$178B
| $7.48M | 0.11% |
38,428
-205
| -0.5% | -$39.9K |
|
|
MORF
123
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.3M | 0.11% |
214,366
| – | – |
|
124
Eli Lilly
LLY
$661B
| $7.28M | 0.11% |
8,039
+917
| +13% | +$830K |
|
125
Vanguard FTSE All-World ex-US ETF
VEU
$48.3B
| $6.74M | 0.1% |
114,939
-66
| -0.1% | -$3.87K |
|